Biomarkers for Predicting Clinical Relapse in Refractory Pemphigus Patients Treated With Rituximab

Pathology - United States
doi 10.1016/j.pathol.2020.01.404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biologic Predictors of Clinical Improvement in Rituximab-Treated Refractory Myositis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2015English

Clinical and Immunological Features of Pemphigus Relapse

British Journal of Dermatology
DermatologyMedicine
2019English

Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab

Frontiers in Medicine
Medicine
2019English

079 Correlation of IgG Autoantibodies Against Acetylcholine Receptors and Desmogleins in Patients With Pemphigus Vulgaris Treated With Steroid Sparing Agents or Rituximab

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated With or Without Rituximab

Thrombosis and Haemostasis
Hematology
2018English

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab

American Journal of Hematology
Hematology
2017English

Rituximab for Refractory Wegener's Granulomatosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2006English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy